Strategic Acquisitions (STQN) Receivables - Other (2022)
Strategic Acquisitions' (STQN) quarterly Receivables - Other came in at $2.2 million in Q4 2022.
Analysis
Strategic Acquisitions (STQN) Receivables - Other (2022) Analysis & Trends
Strategic Acquisitions (STQN) has reported Receivables - Other for 1 consecutive years, with $2.2 million the latest figure, recorded in Q4 2022.
- For the quarter ending Q4 2022, Receivables - Other changed N/A year-over-year to $2.2 million; the trailing twelve-month figure through Dec 2022 stood at $2.2 million (changed N/A YoY), and the FY2022 full-year result was $2.2 million, changed N/A from the prior year.
- Receivables - Other was little changed at $2.2 million in Q4 2022 per STQN's latest filing.
- Across five years, Receivables - Other topped out at $2.2 million in Q4 2022 and bottomed at $2.2 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Orix | 44.18 Bn | 44.51 Bn | 4.68 Bn |
| 2 | Royalty Pharma | 33.59 Bn | 35.70 Bn | - |
| 3 | Royal Gold | 21.14 Bn | 21.00 Bn | 390.45 Mn |
| 4 | OR Royalties | 6.88 Bn | 6.81 Bn | 82.22 Mn |
| 5 | Encore Capital | 2.11 Bn | 1.93 Bn | 455.04 Mn |
| 6 | Atlanticus Holdings | 1.41 Bn | 851.50 Mn | 686.46 Mn |
| 7 | Jefferson Capital | 1.18 Bn | 1.16 Bn | - |
| 8 | Lufax Holding | 1.04 Bn | -1.23 Bn | - |
| 9 | Upbound | 998.67 Mn | 893.37 Mn | 594.84 Mn |
| 10 | Strategic Acquisitions | 18.20 Mn | 17.95 Mn | - |